AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Carfilnat Injection

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Carfilzomib (60mg)

Overview Carfilnat Injection

Carfilnat Injection treats multiple myeloma by inhibiting or reducing cancer cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include tiredness, nausea, and fever. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Report any fever, chills, musculoskeletal pain, facial flushing or swelling, or chest pain immediately. Maintain adequate hydration during treatment. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, including those for infections, to your doctor. Drug interactions are possible; inform your healthcare provider of all medications you are taking. This injection is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners throughout treatment.

Primary Ingredients of Carfilnat Injection

No text provided to rephrase.

Uses of Carfilnat Injection

Plasma cell malignancy

Major Benefits of Carfilnat Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Carfilnat Injection:

  • Fatigue
  • Anemia (low number of red blood cells)
  • Nausea
  • Low blood platelets
  • Fever

How to use Carfilnat Injection:

The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Carfilnat Injection works:

Carfilzomib injection is a cancer treatment that functions by inhibiting the cellular degradation of proteins. This accumulation of proteins within cancerous cells ultimately triggers their demise.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Carfilnat Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Carfilnat Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administering Carfilnat Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Carfilnat Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects are experienced.

KidneyKidneyCAUTION

Carfilnat Injection requires careful administration in individuals with impaired renal function. Dosage modification for Carfilnat Injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should receive Carfilnat Injection with careful monitoring. Dosage modification may be necessary for these patients. Physician consultation is recommended.

What if you forget to take Carfilnat Injection :

NA

Facts to Know About Carfilnat Injection

LabelValue
Chemical Classification Epoxomicin Analog
Developing Habits No.
Treatment Category Cancer Treatments
Actions Proteasome inhibitor drug

FAQs on Carfilnat Injection

Carfilzomib injection, used with other drugs, treats patients with relapsed or refractory multiple myeloma. Consult your doctor if you have any questions.
Carfilzomib (Carfilnat) is administered via intravenous (IV) infusion, delivering medication directly into the bloodstream.
This injection is administered in four-week treatment cycles. Each cycle involves treatment on some days and rest days. Typically, you'll receive Carfilnat Injection two days a week for three weeks, followed by a treatment-free fourth week. Your doctor will personalize your treatment schedule.
This medication may cause nausea and fatigue. Eating smaller, more frequent meals can help alleviate nausea. Avoid salty, spicy, fatty, or fried foods. Rest adequately and engage in light daily exercise to combat fatigue.
This medication may lower your platelet count, increasing your risk of infection. To minimize this risk, avoid contact with sick individuals and crowded places. Practice frequent handwashing, especially after using the restroom.
Seek immediate medical attention if you experience shortness of breath, prolonged or excessive bleeding, jaundice (yellowing of the skin and eyes), severe headache, confusion, seizures, or vision loss.
Carfilzomib injection may harm a developing fetus. Women should use reliable contraception during and for six months after treatment. Men should use reliable contraception during and for three months after treatment.
This medication may transfer to breast milk, potentially harming your baby. Avoid breastfeeding throughout treatment and for two weeks following your last dose.
Carfilnat Injection may cause dehydration; increase your fluid intake accordingly. Dizziness is a possible side effect; avoid driving or operating machinery. To prevent rashes, limit sun exposure and use SPF 15 (or higher) sunscreen with protective clothing.
Carfilnat Injection
8,200
MRP 9,990
17% off